HMR is a Contract Research Organisation (CRO). We specialise in and can provide a full service for phase 1 and early phase 2 studies. Our premises are spacious (5995 m²) and have 145 beds, a sleep unit for polysomnography, facilities for volunteers, laboratories, a pharmacy, including an aseptic unit and radiopharmacy, and offices. We have over 250 staff – 10 physicians, 35 nurses or nurse graduates, and over 200 graduates or PhD. We have done over 850 studies since 1993. HMR is one of the largest early-phase CROs in Europe.
$56K sweet spot round size
1993
$56K
from investors over 1 rounds
Hammersmith Medicines Research Ltd raised $56K on June 1, 2015